Characterization of Subvisible Particles in Protein and Viral Vaccines


21st May 2019 | 10.00 am EST | Marina Kirkitadze,Head of Process Support & PAT Platform, Analytical Sciences at Sanofi Pasteur |BOOK FREE SEAT

The topic of this presentation is a characterisation of visible and subvisible particles in protein and viral vaccine formulations. Visible and subvisible particles were found to be inherent to the product and were analyzed by several methods including MFI, DLS and PALS.

Presented by Marina Kirkitadze, Head of Process Support & PAT Platform, Analytical Sciences at Sanofi Pasteur

Marina Kirkitadze is Head of Biophysics and Conformation Unit at Biochemistry Platform, Analytical R&D North America, Sanofi Pasteur Ltd., Toronto, Canada. She has 17 years’ experience in the vaccine industry. Marina received her PhD in Biological Sciences at the Institute of Protein Research, Russian Academy of Sciences, Pushchino, Russia, and her MBA from the University of Phoenix, AZ, USA. Marina’s main focus is a characterization of vaccine components, specifically, protein conformation and stability in solution and in adjuvanted form.

Sponsored by ProteinSimple

Bio-Techne is a global life sciences company providing innovative tools and bioactive reagents for research and clinical diagnostic communities. Bio-Techne’s product portfolio, representing the biomedical research brands of R&D Systems, Novus Biologicals, Tocris, ProteinSimple and ACD, assists scientific investigations into biological processes and the nature and progress of specific diseases. Additionally, Bio-Techne has announced an initiative to advance cell and gene therapy research and ex vivo cell processing as part of its mission of providing “Pioneering Cell and Gene Therapy Solutions from Discovery to the Clinic.”


We will not sell your information to a third party. See our Privacy Policy